Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.

E F Juniper, G H Guyatt, R S Epstein, P J Ferrie, R Jaeschke, T K Hiller

Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.

BACKGROUND: In the past only physiological and clinical outcomes have been used to assess the effect of asthma interventions and the effect of the intervention on the lives of the patients has not been determined. The objective of this study was to assess health related impairment of quality of life in adult asthmatic patients and to develop a questionnaire for measuring quality of life in clinical trials in asthma. METHODS: Impairment of quality of life in adults with asthma was evaluated from structured interviews in which patients were asked to identify the parts of their daily lives affected by asthma. On the basis of these results, an asthma quality of life questionnaire was developed in an interviewer and self administered form and tested for comprehension and acceptability. A total of 150 adults with asthma and with a wide range of airway hyperresponsiveness were enrolled from previous clinical trials, local asthma clinics, and notices in the media. RESULTS: Areas of quality of life impairment included symptoms classically associated with asthma, responses to environmental stimuli, the need to avoid these stimuli, limitation of activities, and emotional dysfunction. Areas of impairment were similar across strata of airway hyperresponsiveness, age, and treatment requirements and between sexes, thus allowing a single questionnaire suitable for all adults with asthma to be developed. The questionnaire contains 32 items and takes 5-10 minutes to administer; in the pretesting it was shown to be acceptable to a wide range of patients. CONCLUSIONS: The questionnaire includes areas of quality of life impairment that are important to adult asthmatic patients. It has been designed to be responsive to within subject change and therefore may be used as a measure of outcome in clinical trials in asthma.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Power, S., Gallagher, J., Meaney, S. (2009). Quality of life in health care workers with latex allergy. Occup Med (Lond) 0: kqp156v1-kqp156 [Abstract] [Full Text]  
• Rose, M. S., Koshman, M.-L., Ritchie, D., Sheldon, R. (2009). The development and preliminary validation of a scale measuring the impact of syncope on quality of life. Europace 11: 1369-1374 [Abstract] [Full Text]  
• Reddel, H. K., Taylor, D. R., Bateman, E. D., Boulet, L.-P., Boushey, H. A., Busse, W. W., Casale, T. B., Chanez, P., Enright, P. L., Gibson, P. G., de Jongste, J. C., Kerstjens, H. A. M., Lazarus, S. C., Levy, M. L., O'Byrne, P. M., Partridge, M. R., Pavord, I. D., Sears, M. R., Sterk, P. J., Stoloff, S. W., Sullivan, S. D., Szefler, S. J., Thomas, M. D., Wenzel, S. E., on behalf of the American Thoracic Society/Europea, (2009). An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations: Standardizing Endpoints for Clinical Asthma Trials and Clinical Practice. Am. J. Respir. Crit. Care Med. 180: 59-99 [Abstract] [Full Text]  
• Malo, J.-L., L'Archeveque, J., Castellanos, L., Lavoie, K., Ghezzo, H., Maghni, K. (2009). Long-Term Outcomes of Acute Irritant-induced Asthma. Am. J. Respir. Crit. Care Med. 179: 923-928 [Abstract] [Full Text]  
• Wenzel, S. E., Barnes, P. J., Bleecker, E. R., Bousquet, J., Busse, W., Dahlen, S.-E., Holgate, S. T., Meyers, D. A., Rabe, K. F., Antczak, A., Baker, J., Horvath, I., Mark, Z., Bernstein, D., Kerwin, E., Schlenker-Herceg, R., Lo, K. H., Watt, R., Barnathan, E. S., Chanez, P., on behalf of the T03 Asthma Investigators, (2009). A Randomized, Double-blind, Placebo-controlled Study of Tumor Necrosis Factor-{alpha} Blockade in Severe Persistent Asthma. Am. J. Respir. Crit. Care Med. 179: 549-558 [Abstract] [Full Text]  
• Martinez, F. D. (2009). Managing Childhood Asthma: Challenge of Preventing Exacerbations. Pediatrics 123: S146-S150 [Abstract] [Full Text]  
• Denning, D. W., O'Driscoll, B. R., Powell, G., Chew, F., Atherton, G. T., Vyas, A., Miles, J., Morris, J., Niven, R. M. (2009). Randomized Controlled Trial of Oral Antifungal Treatment for Severe Asthma with Fungal Sensitization: The Fungal Asthma Sensitization Trial (FAST) Study. Am. J. Respir. Crit. Care Med. 179: 11-18 [Abstract] [Full Text]  
• Polley, L., Yaman, N., Heaney, L., Cardwell, C., Murtagh, E., Ramsey, J., MacMahon, J., Costello, R. W., McGarvey, L. (2008). Impact of Cough Across Different Chronic Respiratory Diseases: Comparison of Two Cough-Specific Health-Related Quality of Life Questionnaires. Chest 134: 295-302 [Abstract] [Full Text]  
• Shuldham, C., Fleming, S., Yorke, J. (2008). Undertaking a systematic review: the road to successful completion. Journal of Research in Nursing 13: 282-298 [Abstract]  
• Bousquet, J., Wahn, U., Meltzer, E. O., Fox, H., Hedgecock, S., Thomas, K., Fowler-Taylor, A. (2008). Omalizumab: an anti-immunoglobulin E antibody for the treatment of allergic respiratory diseases. ERR 17: 1-9 [Abstract] [Full Text]  
• Netuveli, G., Blane, D. (2008). Quality of life in older ages. Br Med Bull 85: 113-126 [Abstract] [Full Text]  
• Buhl, R. (2007). Anti-IgE: lessons from clinical trials in patients with severe allergic asthma symptomatic despite optimised therapy. ERR 16: 73-77 [Abstract] [Full Text]  
• Holgate, S. T. (2007). How to evaluate a patient's response to anti-IgE. ERR 16: 78-84 [Abstract] [Full Text]  
• Clark, N. M., Gong, Z. M., Wang, S. J., Lin, X., Bria, W. F., Johnson, T. R. (2007). A Randomized Trial of a Self-Regulation Intervention for Women With Asthma. Chest 132: 88-97 [Abstract] [Full Text]  
• Al-Showair, R. A.M., Pearson, S. B., Chrystyn, H. (2007). The Potential of a 2Tone Trainer To Help Patients Use Their Metered-Dose Inhalers. Chest 131: 1776-1782 [Abstract] [Full Text]  
• Yacoub, M-R., Lavoie, K., Lacoste, G., Daigle, S., L'Archeveque, J., Ghezzo, H., Lemiere, C., Malo, J-L. (2007). Assessment of impairment/disability due to occupational asthma through a multidimensional approach. Eur Respir J 29: 889-896 [Abstract] [Full Text]  
• Lafond, C., Series, F., Lemiere, C. (2007). Impact of CPAP on asthmatic patients with obstructive sleep apnoea. Eur Respir J 29: 307-311 [Abstract] [Full Text]  
• Bateman, E. D., Bousquet, J., Keech, M. L., Busse, W. W., Clark, T. J. H., Pedersen, S. E., on behalf of the GOAL Investigators Group, (2007). The correlation between asthma control and health status: the GOAL study. Eur Respir J 29: 56-62 [Abstract] [Full Text]  
• Miller, M. K., Lee, J. H., Blanc, P. D., Pasta, D. J., Gujrathi, S., Barron, H., Wenzel, S. E., Weiss, S. T., for the TENOR Study Group, (2006). TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma. Eur Respir J 28: 1145-1155 [Abstract] [Full Text]  
• Pickard, A S., Hung, S.-Y. (2006). An Update on Evidence of Clinical Pharmacy Services' Impact on Health-Related Quality of Life. The Annals of Pharmacotherapy 40: 1623-1634 [Abstract] [Full Text]  
• Chen, H., Eisner, M. D., Katz, P. P., Yelin, E. H., Blanc, P. D. (2006). Measuring Disease-Specific Quality of Life in Obstructive Airway Disease: Validation of a Modified Version of the Airways Questionnaire 20. Chest 129: 1644-1652 [Abstract] [Full Text]  
• Green, R. H., Brightling, C. E., McKenna, S., Hargadon, B., Neale, N., Parker, D., Ruse, C., Hall, I. P., Pavord, I. D. (2006). Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness. Eur Respir J 27: 1144-1151 [Abstract] [Full Text]  
• De Smet, B. D, Erickson, S. R, Kirking, D. M (2006). Self-Reported Adherence in Patients with Asthma. The Annals of Pharmacotherapy 40: 414-420 [Abstract] [Full Text]  
• Lemaigre, V., Van den Bergh, O., Van Hasselt, K., De Peuter, S., Victoir, A., Verleden, G. (2005). Understanding Participation in an Asthma Self-Management Program. Chest 128: 3133-3139 [Abstract] [Full Text]  
• Ross, C. J. M., Davis, T. M. A., Macdonald, G. F. (2005). Cognitive-Behavioral Treatment Combined With Asthma Education for Adults With Asthma and Coexisting Panic Disorder. Clin Nurs Res 14: 131-157 [Abstract]  
• Barley, E. A., Jones, P. W. (2005). Analysis of the cues used by patients when making assessments of their asthma severity. Eur Respir J 25: 671-676 [Abstract] [Full Text]  
• Clini, E M, Romagnoli, M (2005). Inpatient pulmonary rehabilitation: does it make sense?. Chronic Respiratory Disease 2: 43-46 [Abstract]  
• Bateman, E. D., Boushey, H. A., Bousquet, J., Busse, W. W., Clark, T. J. H., Pauwels, R. A., Pedersen, S. E., for the GOAL Investigators Group, (2004). Can Guideline-defined Asthma Control Be Achieved?: The Gaining Optimal Asthma ControL Study. Am. J. Respir. Crit. Care Med. 170: 836-844 [Abstract] [Full Text]  
• Lynd, L. D., Sandford, A. J., Kelly, E. M., Pare, P. D., Bai, T. R., FitzGerald, J. M., Anis, A. H. (2004). Reconcilable Differences: A Cross-sectional Study of the Relationship Between Socioeconomic Status and the Magnitude of Short-Acting {beta}-Agonist Use in Asthma. Chest 126: 1161-1168 [Abstract] [Full Text]  
• Bumbacea, D., Campbell, D., Nguyen, L., Carr, D., Barnes, P.J., Robinson, D., Chung, K.F. (2004). Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J 24: 122-128 [Abstract] [Full Text]  
• Cudkowicz, M. E., Schoenfeld, D., Williams, L. (2004). Improving the responsiveness of rating scales: The challenge of stepping twice into the same river. Neurology 62: 1666-1667 [Full Text]  
• Pont, L.G., van der Molen, T., Denig, P., van der Werf, G.T., Haaijer-Ruskamp, F.M. (2004). Relationship between guideline treatment and health-related quality of life in asthma. Eur Respir J 23: 718-722 [Abstract] [Full Text]  
• Bousquet, J., Wenzel, S., Holgate, S., Lumry, W., Freeman, P., Fox, H. (2004). Predicting Response to Omalizumab, an Anti-IgE Antibody, in Patients With Allergic Asthma. Chest 125: 1378-1386 [Abstract] [Full Text]  
• Campbell, J.L., Kiebert, G.M., Partridge, M.R. (2003). Development of the Satisfaction with Inhaled Asthma Treatment Questionnaire. Eur Respir J 22: 127-134 [Abstract] [Full Text]  
• Lee, T. A., Hollingworth, W., Sullivan, S. D. (2003). Comparison of Directly Elicited Preferences to Preferences Derived from the SF-36 in Adults with Asthma. Med Decis Making 23: 323-334 [Abstract]  
• Vaquerizo, M J, Casan, P, Castillo, J, Perpina, M, Sanchis, J, Sobradillo, V, Valencia, A, Verea, H, Viejo, J L, Villasante, C, Gonzalez-Esteban, J, Picado, C (2003). Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax 58: 204-210 [Abstract] [Full Text]  
• Price, D B, Hernandez, D, Magyar, P, Fiterman, J, Beeh, K M, James, I G, Konstantopoulos, S, Rojas, R, van Noord, J A, Pons, M, Gilles, L, Leff, J A (2003). Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax 58: 211-216 [Abstract] [Full Text]  
• Thomas, M, McKinley, R K, Freeman, E, Foy, C, Prodger, P, Price, D (2003). Breathing retraining for dysfunctional breathing in asthma: a randomised controlled trial. Thorax 58: 110-115 [Abstract] [Full Text]  
• Put, C., van den Bergh, O., Lemaigre, V., Demedts, M., Verleden, G. (2003). Evaluation of an individualised asthma programme directed at behavioural change. Eur Respir J 21: 109-115 [Abstract] [Full Text]  
• Ford, E. S., Mannino, D. M., Homa, D. M., Gwynn, C., Redd, S. C., Moriarty, D. G., Mokdad, A. H. (2003). Self-Reported Asthma and Health-Related Quality of Life: Findings From the Behavioral Risk Factor Surveillance System. Chest 123: 119-127 [Abstract] [Full Text]  
• Thoonen, B P A, Schermer, T R J, van den Boom, G, Molema, J, Folgering, H, Akkermans, R P, Grol, R, van Weel, C, van Schayck, C P (2003). Self-management of asthma in general practice, asthma control and quality of life: a randomised controlled trial. Thorax 58: 30-36 [Abstract] [Full Text]  
• Buhl, R., Hanf, G., Soler, M., Bensch, G., Wolfe, J., Everhard, F., Champain, K., Fox, H., Thirlwell, J. (2002). The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma. Eur Respir J 20: 1088-1094 [Abstract] [Full Text]  
• Zhang, J., Yu, C., Holgate, S.T., Reiss, T.F. (2002). Variability and lack of predictive ability of asthma end-points in clinical trials. Eur Respir J 20: 1102-1109 [Abstract] [Full Text]  
• McDonald, E., Cook, D., Newman, T., Griffith, L., Cox, G., Guyatt, G. (2002). Effect of Air Filtration Systems on Asthma: A Systematic Review of Randomized Trials. Chest 122: 1535-1542 [Abstract] [Full Text]  
• Schermer, T. R., Thoonen, B. P., van den Boom, G., Akkermans, R. P., Grol, R. P., Folgering, H. T., van Weel, C., van Schayck, C. P. (2002). Randomized Controlled Economic Evaluation of Asthma Self-Management in Primary Health Care. Am. J. Respir. Crit. Care Med. 166: 1062-1072 [Abstract] [Full Text]  
• Weinberger, M., Murray, M. D., Marrero, D. G., Brewer, N., Lykens, M., Harris, L. E., Seshadri, R., Caffrey, H., Roesner, J. F., Smith, F., Newell, A. J., Collins, J. C., McDonald, C. J., Tierney, W. M. (2002). Effectiveness of Pharmacist Care for Patients With Reactive Airways Disease: A Randomized Controlled Trial. JAMA 288: 1594-1602 [Abstract] [Full Text]  
• Oga, T., Nishimura, K., Tsukino, M., Sato, S., Hajiro, T., Mishima, M. (2002). Comparison of the Responsiveness of Different Disease-Specific Health Status Measures in Patients With Asthma. Chest 122: 1228-1233 [Abstract] [Full Text]  
• Price, D, Dutchman, D, Mawson, A, Bodalia, B, Duggan, S, Todd, P (2002). Early asthma control and maintenance with eformoterol following reduction of inhaled corticosteroid dose. Thorax 57: 791-798 [Abstract] [Full Text]  
• Juniper, E. F., Price, D. B., Stampone, P. A., Creemers, J. P. H. M., Mol, S. J. M., Fireman, P. (2002). Clinically Important Improvements in Asthma-Specific Quality of Life, But No Difference in Conventional Clinical Indexes in Patients Changed From Conventional Beclomethasone Dipropionate to Approximately Half the Dose of Extrafine Beclomethasone Dipropionate*. Chest 121: 1824-1832 [Abstract] [Full Text]  
• Jones, P.W. (2002). Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 19: 398-404 [Abstract] [Full Text]  
• FLEMONS, W. W., REIMER, M. A. (2002). Measurement Properties of the Calgary Sleep Apnea Quality of Life Index. Am. J. Respir. Crit. Care Med. 165: 159-164 [Abstract] [Full Text]  
• DAHLEN, S.-E., MALMSTROM, K., NIZANKOWSKA, E., DAHLEN, B., KUNA, P., KOWALSKI, M., LUMRY, W. R., PICADO, C., STEVENSON, D. D., BOUSQUET, J., PAUWELS, R., HOLGATE, S. T., SHAHANE, A., ZHANG, J., REISS, T. F., SZCZEKLIK, A. (2002). Improvement of Aspirin-Intolerant Asthma by Montelukast, a Leukotriene Antagonist . A Randomized, Double-Blind, Placebo-Controlled Trial. Am. J. Respir. Crit. Care Med. 165: 9-14 [Abstract] [Full Text]  
• Muntner, P., Sudre, P., Uldry, C., Rochat, T., Courteheuse, C., Naef, A.-F., Perneger, T. V. (2001). Predictors of Participation and Attendance in a New Asthma Patient Self-Management Education Program. Chest 120: 778-784 [Abstract] [Full Text]  
• Juniper, E.F., Norman, G.R., Cox, F.M., Roberts, J.N. (2001). Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma. Eur Respir J 18: 38-44 [Abstract] [Full Text]  
• Lemanske, R. F. Jr, Sorkness, C. A., Mauger, E. A., Lazarus, S. C., Boushey, H. A., Fahy, J. V., Drazen, J. M., Chinchilli, V. M., Craig, T., Fish, J. E., Ford, J. G., Israel, E., Kraft, M., Martin, R. J., Nachman, S. A., Peters, S. P., Spahn, J. D., Szefler, S. J., for the Asthma Clinical Research Network of the Na, (2001). Inhaled Corticosteroid Reduction and Elimination in Patients With Persistent Asthma Receiving Salmeterol: A Randomized Controlled Trial. JAMA 285: 2594-2603 [Abstract] [Full Text]  
• CÔTÉ, J., BOWIE, D. M., ROBICHAUD, P., PARENT, J.-G., BATTISTI, L., BOULET, L.-P. (2001). Evaluation of Two Different Educational Interventions for Adult Patients Consulting with an Acute Asthma Exacerbation. Am. J. Respir. Crit. Care Med. 163: 1415-1419 [Abstract] [Full Text]  
• MOY, M. L., ISRAEL, E., WEISS, S. T., JUNIPER, E. F., DUBÉ, L., DRAZEN, J. M., the NHLBI Asthma Clinical Rese, (2001). Clinical Predictors of Health-related Quality of Life Depend on Asthma Severity. Am. J. Respir. Crit. Care Med. 163: 924-929 [Abstract] [Full Text]  
• Shingo, S., Zhang, J., Reiss, T.F. (2001). Correlation of airway obstruction and patient-reported endpoints in clinical studies. Eur Respir J 17: 220-224 [Abstract] [Full Text]  
• THOMAS, M, BARNES, N C (2001). Outcome measures in asthma. Thorax 56: 161a-161 [Full Text]  
• Rutishauser, C., Sawyer, S.M., Bond, L., Coffey, C., Bowes, G. (2001). Development and validation of the Adolescent Asthma Quality of Life Questionnaire (AAQOL). Eur Respir J 17: 52-58 [Abstract] [Full Text]  
• Clark, N. M. (2000). Understanding Individual and Collective Capacity to Enhance Quality of Life. Health Educ Behav 27: 699-707  
• LEYNAERT, B., NEUKIRCH, C., LIARD, R., BOUSQUET, J., NEUKIRCH, F. (2000). Quality of Life in Allergic Rhinitis and Asthma . A Population-based Study of Young Adults. Am. J. Respir. Crit. Care Med. 162: 1391-1396 [Abstract] [Full Text]  
• Lim, S., Jatakanon, A., Gordon, D., Macdonald, C., Chung, K. F., Barnes, P. J (2000). Comparison of high dose inhaled steroids, low dose inhaled steroids plus low dose theophylline, and low dose inhaled steroids alone in chronic asthma in general practice. Thorax 55: 837-841 [Abstract] [Full Text]  
• van den TOORN, L. M., PRINS, J.-B., OVERBEEK, S. E., HOOGSTEDEN, H. C., de JONGSTE, J. C. (2000). Adolescents in Clinical Remission of Atopic Asthma Have Elevated Exhaled Nitric Oxide Levels and Bronchial Hyperresponsiveness. Am. J. Respir. Crit. Care Med. 162: 953-957 [Abstract] [Full Text]  
• Eccles, M., Grimshaw, J., Steen, N., Parkin, D., Purves, I., McColl, E., Rousseau, N. (2000). The design and analysis of a randomized controlled trial to evaluate computerized decision support in primary care: the COGENT study. Fam Pract 17: 180-186 [Full Text]  
• Moudgil, H, Marshall, T, Honeybourne, D (2000). Asthma education and quality of life in the community: a randomised controlled study to evaluate the impact on white European and Indian subcontinent ethnic groups from socioeconomically deprived areas in Birmingham, UK. Thorax 55: 177-183 [Abstract] [Full Text]  
• Hoskins, G, McCowan, C, Neville, R G, Thomas, G E, Smith, B, Silverman, S (2000). Risk factors and costs associated with an asthma attack. Thorax 55: 19-24 [Abstract] [Full Text]  
• LAVIOLETTE, M., MALMSTROM, K., LU, S., CHERVINSKY, P., PUJET, J.-C., PESZEK, I., ZHANG, J., REISS, T. F. (1999). Montelukast Added to Inhaled Beclomethasone in Treatment of Asthma. Am. J. Respir. Crit. Care Med. 160: 1862-1868 [Abstract] [Full Text]  
• Juniper, E. F., Buist, A. S. (1999). Health-Related Quality of Life in Moderate Asthma: 400 {micro}g Hydrofluoroalkane Beclomethasone Dipropionate vs 800 {micro}g Chlorofluorocarbon Beclomethasone Dipropionate. Chest 116: 1297-1303 [Abstract] [Full Text]  
• VOLLMER, W. M., MARKSON, L. E., O'CONNOR, E., SANOCKI, L. L., FITTERMAN, L., BERGER, M., SONIA BUIST, A. (1999). Association of Asthma Control with Health Care Utilization and Quality of Life. Am. J. Respir. Crit. Care Med. 160: 1647-1652 [Abstract] [Full Text]  
• RUBENFELD, G. D., ANGUS, D. C., PINSKY, M. R., CURTIS, J. R., CONNORS, A. F. Jr., BERNARD, G. R., The Members of the Outcomes Re, (1999). Outcomes Research in Critical Care . Results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research. Am. J. Respir. Crit. Care Med. 160: 358-367 [Full Text]  
• Rowe, B. H., Bota, G. W., Fabris, L., Therrien, S. A., Milner, R. A., Jacono, J. (1999). Inhaled Budesonide in Addition to Oral Corticosteroids to Prevent Asthma Relapse Following Discharge From the Emergency Department: A Randomized Controlled Trial. JAMA 281: 2119-2126 [Abstract] [Full Text]  
• Juniper, E. F., Buist, A. S., Cox, F. M., Ferrie, P. J., King, D. R. (1999). Validation of a Standardized Version of the Asthma Quality of Life Questionnaire. Chest 115: 1265-1270 [Abstract] [Full Text]  
• Malmstrom, K., Rodriguez-Gomez, G., Guerra, J., Villaran, C., Pineiro, A., Wei, L. X., Seidenberg, B. C., Reiss, T. F., for the Montelukast/Beclomethasone Study Group*, (1999). Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic Asthma: A Randomized, Controlled Trial. ANN INTERN MED 130: 487-495 [Abstract] [Full Text]  
• GALLEFOSS, F., BAKKE, P. S., KJAERSGAARD, P. (1999). Quality of Life Assessment after Patient Education in a Randomized Controlled Study on Asthma and Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 159: 812-817 [Abstract] [Full Text]  
• LEIDY, N. K., CHAN, K. S., COUGHLIN, C. (1998). Is the Asthma Quality of Life Questionnaire a Useful Measure for Low-income Asthmatics?. Am. J. Respir. Crit. Care Med. 158: 1082-1090 [Abstract] [Full Text]  
• WARD FLEMONS, W., REIMER, M. A. (1998). Development of a Disease-specific Health-related Quality of Life Questionnaire for Sleep Apnea. Am. J. Respir. Crit. Care Med. 158: 494-503 [Abstract] [Full Text]  
• Reiss, T. F., Chervinsky, P., Dockhorn, R. J., Shingo, S., Seidenberg, B., Edwards, T. B., for the Montelukast Clinical Research Study Group, (1998). Montelukast, a Once-Daily Leukotriene Receptor Antagonist, in the Treatment of Chronic Asthma: A Multicenter, Randomized, Double-blind Trial. Arch Intern Med 158: 1213-1220 [Abstract] [Full Text]  
• Nanda, U., Andresen, E. M. (1998). Health-Related Quality of Life: A Guide for the Health Professional. Eval Health Prof 21: 179-215 [Abstract]  
• RANDALL CURTIS, J., RUBENFELD, G. D., HUDSON, L. D. (1998). Training Pulmonary and Critical Care Physicians in Outcomes Research . Should We Take the Challenge?. Am. J. Respir. Crit. Care Med. 157: 1012-1015 [Full Text]  
• Guyatt, G. H, Juniper, E. F, Walter, S. D, Griffith, L. E, Goldstein, R. S (1998). Interpreting treatment effects in randomised trials. BMJ 316: 690-693 [Full Text]  
• Schwartz, H. J., Petty, T., Dube, L. M., Swanson, L. J., Lancaster, J. F., for the Zileuton Study Group, (1998). A Randomized Controlled Trial Comparing Zileuton With Theophylline in Moderate Asthma. Arch Intern Med 158: 141-148 [Abstract] [Full Text]  
• Blaiss, M. S. (1997). Outcomes Analysis in Asthma. JAMA 278: 1874-1880 [Abstract]  
• CURTIS, J. R., MARTIN, D. P., MARTIN, T. R. (1997). Patient-assessed Health Outcomes in Chronic Lung Disease . What are They, How Do They Help Us, and Where Do We Go From Here?. Am. J. Respir. Crit. Care Med. 156: 1032-1039 [Full Text]  
• TURNER, M. O., TAYLOR, D., BENNETT, R., MARK FITZGERALD, J. (1997). A Randomized Trial Comparing Peak Expiratory Flow and Symptom Self-management Plans for Patients with Asthma Attending a Primary Care Clinic. Am. J. Respir. Crit. Care Med. 157: 540-546 [Abstract] [Full Text]  
• Drazen, J. M., Israel, E., Boushey, H. A., Chinchilli, V. M., Fahy, J. V., Fish, J. E., Lazarus, S. C., Lemanske, R. F., Martin, R. J., Peters, S. P., Sorkness, C., Szefler, S. J., The National Heart Lung andBlood Institute's Asthm, (1996). Comparison of Regularly Scheduled with As-Needed Use of Albuterol in Mild Asthma. NEJM 335: 841-847 [Abstract] [Full Text]  
• Testa, M. A., Simonson, D. C. (1996). Assessment of Quality-of-Life Outcomes. NEJM 334: 835-840 [Full Text]